SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$0.40
+0.00 (+0.75%)
Financial Highlights (FY 2026)
Revenue
731.6K
Net Income
-50,659,034
Gross Margin
Profit Margin
-6,925.2%
Rev Growth
-47.4%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.7% 31.7%
Operating Margin -7,907.8% -7,117.0% 16.0% 12.9%
Profit Margin -6,925.2% -6,578.9% 11.6% 16.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 731.6K 1.39M 2.02M 1.51M
Gross Profit 641.3K 476.9K
Operating Income -57,853,877 -98,970,707 323.1K 193.8K
Net Income -50,659,034 -86,662,479 234.8K 245.0K
Gross Margin 31.7% 31.7%
Operating Margin -7,907.8% -7,117.0% 16.0% 12.9%
Profit Margin -6,925.2% -6,578.9% 11.6% 16.3%
Rev Growth -47.4% -47.4% +14.4% +1.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.44M 1.44M 3.18M 3.12M
Total Equity 4.31M 4.31M 9.01M 7.78M
D/E Ratio 0.33 0.33 0.35 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -56,050,956 -101,213,473 368.8K 310.9K
Free Cash Flow 168.2K 121.5K